Market Overview
Increasing incidents of cardiovascular ailments among the expanding populace is predicted to be a salient factor that can boost the angiography equipment market 2020. The introduction of supportive reimbursement policies by various governments to cure heart disorders is projected to escalate the demand for advanced treatment that can grow the market. Other salient factors, such as; increasing healthcare expenditure and the on-going technical development, are expected to further actuate the demand for efficient treatment, which is likely to expand the angiography equipment trade.
According to Market Research Future (MRFR), the global angiography equipment market is anticipated to acquire a significant market value, thriving at a CAGR of 5.2% during the review period from 2018-2023.
Regional Analysis
As per the analysis, the global market is anticipated to be dominated by Europe due to the growing incidences of cardiovascular disorders and the on-going technological development. The growing demand for minimally invasive devices is predicted to grow the market in the coming period.
North America is anticipated to acquire the second largest market share during the review period owing to the rising rise of cardiac diseases. The growing geriatric population is expected to grow the demand for advanced medical tools in the coming period. The presence of the U.S. and Canada is projected to be a salient factor that can boost the regional market considerably.
The APAC region is expected to be driven majorly by China, Japan, and India, owing to their fast developing healthcare infrastructure. The expanding patient pool with a rising geriatric population is likely to grow the regional market in the coming period.
Key Players
Key players of the global angiography market players are G.E. Healthcare (U.S.), Boston Scientific Corporation (U.S.), Canon Corporation (Japan), Medtronic (Ireland), Siemens Healthineers (Germany), Shimadzu Corporation (Japan), Angiodynamics (U.S.), Koninklijke Philips N.V. (Netherlands), Abbott Laboratories (U.S.), B. Braun Melsungen (Germany), Cordis (a Cardinal Health Company, U.S.) and Terumo (Japan)
https://www.marketresearchfuture.com/reports/angiography-equipment-market-6106